Alpha DNA Investment Management’s Calix CALX Stock Holding History

Alpha DNA Investment Management’s Portfolio CALX Stock Details CALX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-16,967	Closed	-$847K	–	177
2023 Q2	$847K	Sell	16,967 -2,845	-14%	-$137K	0.28%	76
2023 Q1	$1.06M	Buy	19,812 +4,001	+25%	+$218K	0.31%	97
2022 Q4	$1.08M	Buy	+15,811	New	+$1.06M	0.38%	86
2022 Q1	–	Sell	-22,078	Closed	-$1.76M	–	124
2021 Q4	$1.76M	Buy	+22,078	New	+$1.44M	1.11%	28
2021 Q3	–	Sell	-29,708	Closed	-$1.41M	–	111
2021 Q2	$1.41M	Buy	29,708 +15,562	+110%	+$683K	0.96%	61
2021 Q1	$489K	Sell	14,146 -1,709	-11%	-$63.3K	0.56%	94
2020 Q4	$471K	Buy	+15,855	New	+$391K	0.5%	93

Other funds holding CALX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Alpha DNA Investment Management's CALX Position: Q3 2023 in Review

Alpha DNA Investment Management sold out of Calix (CALX) in Q3 2023, closing a stake of 16,967 shares — an estimated $847K sold.

Alpha DNA Investment Management first reported a position in CALX in Q4 2020 and held it in 7 quarters. The position peaked at $1.76M in Q4 2021. 276 funds tracked by Wall St. Rank hold CALX as of Q3 2023.

Alpha DNA Investment Management reported no remaining Calix position as of Q3 2023 after selling out during the quarter.
Alpha DNA Investment Management sold 16,967 Calix shares in Q3 2023, an estimated $847K.
Alpha DNA Investment Management first reported a position in Calix in Q4 2020 and held it in 7 quarters.
Alpha DNA Investment Management's Calix position peaked at $1.76M in Q4 2021.
276 funds tracked by Wall St. Rank held Calix as of Q3 2023.

Based on Alpha DNA Investment Management's 13F filing for Q3 2023, filed 7 Nov 2023.